CHU de Bordeaux
Bordeaux, France
NCT Number: NCT07079943
This study evaluates the impact of the CAPAdJA transition support program on care continuity for young patients with chronic rheumatic diseases at Bordeaux University Hospital. The primary objective is to compare the proportion of patients lost to follow-up six months after the transition consultation between those who benefited from CAPAdJA and those who did not.
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
Bordeaux, France
The transition from pediatric to adult healthcare is a critical period for young patients with chronic diseases. This period carries risks such as disruptions in continuity of care, worsening symptoms, and a deterioration in quality of life. To address these challenges, transition support programs have been developed, including the CAPAdJA program, implemented in 2017 at Bordeaux University Hospital. While such programs seem to play a key role in structuring the transition process, their impact on care continuity and patient satisfaction remains poorly documented. The primary objective of this study is to assess the impact of the CAPAdJA program on the proportion of young patients lost to follow-up. Patients included six months after the pediatric-to-adult rheumatology transition consultation realized in the context of programm CAPADJA or not. The secondary objectives are to provide an overview of the medical and demographic characteristics of the transition in rheumatology at Bordeaux University Hospital and to analyze the impact of CAPAdJA on patient satisfaction and quality of life. Demographic and medical data will be collected using Dxcare. Then, patients will be categorized into two groups: those who benefited from the CAPAdJA support program and those who did not. Investigators will then compare the proportion of patients lost to follow-up in each group, as well as their responses to self-administered questionnaires focusing on quality of life and patient satisfaction.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patient satisfaction and quality of life outcomes assessed through standardized self-reported questionnaires completed day of inclusion (6 months after the pediatric-to-adult rheumatology transition consultation realized in the context of programm CAPADJA or not. )
Patient educational or professional outcomes, assessed through standardized self-reported questionnaires completed day of inclusion (6 months after the pediatric-to-adult rheumatology transition consultation realized in the context of programm CAPADJA or not. )
Time frame: six months after the transition appointment
The primary endpoint is the proportion of patients lost to follow-up 6 months after the transition consultation, considered to be an indicator of continuity of care and, by extension, of the medical success of the transition. This criterion will be evaluated by examining the presence or absence of follow-up consultations in the adult rheumatology department, as recorded in the CHU consultation software, six months after the transition appointment.
Contact information is provided by the study sponsor or research team.
Julie PERROT, MD
CONTACT
Olivier RICHER, MD
CONTACT
University Hospital, Bordeaux
Other
From Adolescence to Adulthood : Analysis of the Impact of the CAPADJA Transition Support Program in Rheumatology at Bordeaux University Hospital
Acronym: TRAJ
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07590076
Brain Diseases, Cardiovascular Diseases
Ottawa, Ontario, Canada
View Trial DetailsNCT07478081
Cardiovascular Diseases, Heart Diseases
Bogotá, Bogota D.C., Colombia
View Trial DetailsNCT07731126
Geriatric Multimorbidity, Remote Patient Monitoring (RPM)
Ancona, Italy
View Trial DetailsNCT07660237
Behavior, Behavioral Symptoms
Guishan, Taoyuan City, Taiwan
View Trial Details